Dr John Lee | Senior Vice President, Adult Medical Affairs. Co-Director, Chan Soon-Shiong Institutes for Medicine

Dr John Lee, Senior Vice President, Adult Medical Affairs. Co-Director, Chan Soon-Shiong Institutes for Medicine, NantKwest

John Lee grew up on a small dairy farm in Northern Minnesota.  He did his undergraduate education at Stanford University graduating with honors in biology.  He completed his medical school at University of Minnesota.  Residency and fellowship were performed in Head and Neck Surgery at the University of Iowa.  He stayed on staff and was promoted to associate professor.  During time from undergraduate throughout his career he has focused not only on medical training but also translational research.  In 2008, Dr. Lee took a position to build a head and neck cancer program at Sanford Health.  While there as the physician lead for the system he developed a large head and neck program that focuses on bringing immune oncology drugs to patients. Academically, he was promoted to full professor and also was promoted to medical director of oncology research.  He initiated and chaired the systems protocol review committee for all incoming oncology trials and developed several initiated trials within Sanford.  In addition, his lab produced over 40 peer-reviewed papers, multiple patents and maintained continuous NIH funding.  Dr. Lee has a passion is to improve long term cures and reduce morbidity of oncology treatments using the bodies’ immune response.  In 2016, Dr. Lee moved to Southern California to assume the positions of Senior Vice President of Adult Medical Affairs at NantKwest and Co-Director of the Chan Soon-Shiong Institutes for Medicine.  For enjoyment Dr. Lee enjoys the outdoors, especially hunting and fishing.


Agenda Day 2 @ 4:00

Combining innate cellular therapy and adaptive immune therapy approaches for treatment of recurrent cancer

  • Rationale for combination of adenoviral vaccine with “superkine” IL-15 agonist
  • Partnering with NK cell therapy – mechanisms of action
  • Study design and initial safety
  • Early response data

back to speakers